# A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy

> **NCT01789879** · PHASE2 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 60 (actual)

## Conditions studied

- HIV
- Contraception

## Interventions

- **DRUG:** Levonorgestrel
- **DRUG:** Nevirapine
- **DRUG:** Efavirenz

## Key facts

- **NCT ID:** NCT01789879
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-04
- **Primary completion:** 2014-09-01
- **Final completion:** 2015-03-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-09-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01789879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01789879, "A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01789879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*